Login / Signup

Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity.

Mariam RimaCecile EmeraudRemy A BonninCamille GonzalezLaurent DortetBogdan I IorgaSaoussen OueslatiThierry Naas
Published in: The Journal of antimicrobial chemotherapy (2021)
Our data confirm that the R214G mutation (present in OXA-244) results in reduced carbapenem- and temocillin-hydrolysing activity, confirming the crucial role of residue 214 in the hydrolysis of these substrates by OXA-48-like β-lactamases.
Keyphrases
  • acinetobacter baumannii
  • klebsiella pneumoniae
  • multidrug resistant
  • drug resistant
  • pseudomonas aeruginosa
  • escherichia coli
  • gram negative
  • electronic health record
  • cystic fibrosis
  • machine learning